Genmab | L'Utile Operativo



Operating Profit Cambiamento Data
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Almirall EUR 53.03M 68.53M 2024-06
Amarin USD -25168000 24.64M 2024-09
Amgen USD 1.29B 1.02B 2025-03
argenx SE USD 103.04M 86.87M 2024-12
AstraZeneca USD 3.67B 1.64B 2025-03
Bayer EUR 3.53B 7.35B 2024-12
BioMarin Pharmaceutical USD 223.89M 62.49M 2025-03
Demant DKK 2.34B 1.32B 2024-12
Exelixis USD 163.21M 27.13M 2025-01
Fresenius Medical Care EUR 331M 72.1M 2025-03
Galapagos EUR -158708000 95.99M 2025-03
Genmab DKK 2.19B 89M 2024-12
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
GN Store Nord DKK 215M 486M 2025-03
GRIFOLS EUR 371.86M 54.83M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Insmed USD -230414000 16.98M 2024-12
Lonza CHF 534M 194M 2024-06
Merck EUR 1.2B 100M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Regeneron Pharmaceuticals USD 591.7M 398.5M 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 2.28B 1.42B 2025-03
UCB EUR 163M 39M 2024-06



Genmab L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.